ID | PEPTIDE SEQUENCE | PEPTIDE NAME | LENGTH | CHIRALITY | LINEAR/CYCLIC | SOURCE | CATEGORY | N TERMINAL MODIFICATION | C TERMINAL MODIFICATION | CHEMICAL MODIFICATION | CARGO | PUBMED ID |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2001 | rrrrrrrrrcqcrrkn | R9-GO-203 | 16 | D | Linear | Synthetic | Cationic | Free | Free | NA | Small molecule drug (Taxol and doxorubicin) | 23114713 |
2014 | GLWRALWRLLRSLWRLLWRA | CADY | 20 | L | Linear | Synthetic | Amphipathic | Acetylation | Cysteamide group | NA | Nucleic acid (siRNA) | 23036951 |
2039 | LLIILRRRIRKQAHAHSK | FAM-pVEC | 18 | L | Linear | Protein derived | NA | Conjugation with 5(6)-Carboxyfluorescein | Amidation | NA | Fluorophore [5(6)-carboxyfluorescein (FAM)] | 23350661 |
2096 | RQIKIWFQNRRMKWKK | Pen-GFP | 16 | L | Linear | Protein derived | Amphipathic | Free | Free | NA | Protein (eGFP) | 23521800 |
2104 | RXRRXRILFQYRXRRXR | LB1_1 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2105 | RXRRXRYQFLIRXRRXR | LB1_2 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2106 | RXRRXRFLQIYRXRRXR | LB1_3 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2107 | RXRRXRAAAAARXRRXR | LB1_4 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2108 | RXRRXRIKFQYRXRRXR | LB1_5 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2109 | RXRRXRIEFQYRXRRXR | LB1_6 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2110 | RXRRXRIWFQYRXRRXR | LB1_7 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2111 | RXRRXRIPFQYRXRRXR | LB1_8 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2112 | KXRKXRILFQYKXRKXR | LB1_9 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2113 | HXRHXRILFQYHXRHXR | LB1_10 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2114 | SXRSXRILFQYSXRSXR | LB1_11 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2115 | EXREXRILFQYEXREXR | LB1_12 | 17 | Modified | Linear | Synthetic | NA | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2116 | RMKWKKILFQYRXRRXR | LB1_13 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2117 | RXRRXRILFQYRMKWKK | LB1_14 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2118 | KKWKMRILFQYRXRRXR | LB1_15 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2119 | RXRRXRILFQYKKWKMR | LB1_16 | 17 | Modified | Linear | Synthetic | Cationic | N-terminal alkyne is introduced using 4-pentynoic acid | Amidation | X, aminohexyl residue | PNA705 | 24105028 |
2123 | AGYLLGHINLHHLAHLHHIL | TH peptide | 20 | L | Linear | Synthetic | Cationic | Free | Amidation | NA | Nanoparticle (Liposomes) | 23891517 |
2124 | AGYLLGKINLKKLAKLLLIL | TK peptide | 20 | L | Linear | Synthetic | Cationic | Free | Amidation | NA | Nanoparticle (Liposomes) | 23891517 |
2126 | RQIKIWFQNRRMKWKK | L-Penetratin | 16 | L | Linear | Protein derived | Amphipathic | Free | Free | NA | Protein (Insulin) | 24060698 |
2127 | KWFKIQMQIRRWKNKR | PenetraMax | 16 | L | Linear | Synthetic | NA | Free | Free | NA | Protein (Insulin) | 24060698 |
2133 | HHHHHHHHRRRRRRRR | STR-H8R8 | 16 | L | Linear | Synthetic | Cationic | Stearylation | Amidation | NA | Nucleic acid (GAPDH siRNA) | 25193363 |
2154 | KWFETWFTEWPKKRKGGC | Pep-3 | 18 | L | Linear | Synthetic | NA | Free | Free | Linker Di-Glycine | PNA | 25185512 |
2161 | RQIKIWFQNRRMKWKK | Penetratin | 16 | L | Linear | Protein derived | Cationic and amphipathic | Free | Free | NA | Protein (Insulin) | 24973720 |
2162 | rqikiwfqnrrmkwkk | Penetratin | 16 | D | Linear | Protein derived | Cationic and amphipathic | Free | Free | NA | Protein (Insulin) | 24973720 |
2164 | PKKKRKVWKLLQQFFGLM | NS | 18 | L | Linear | Synthetic | Cationic | Free | Amidation | NA | Fluorophore (FITC) | 24958615 |
2165 | PKKKRKVWKLLQQFFGLM | Stearyl-NS | 18 | L | Linear | Synthetic | Cationic | Stearylation | Amidation | NA | Fluorophore (FITC) | 24958615 |
2166 | PKKKRKVWKLLQQFFGLM | FITC-NS | 18 | L | Linear | Synthetic | Cationic | Free | Amidation | Spacer 6-aminohexanoic acid (Ahx) | Fluorophore (FITC) | 24958615 |
2172 | KLALKLALKALKAALKLA | MAP | 18 | L | Linear | Protein derived | Amphipathic | Conjugation with fluorescein | Amidation | NA | Fluorophore (Fluorescein) | 25016968 |
2174 | RQIKIWFQNRRMKWKK | pAntp | 16 | L | Linear | Protein derived | Cationic and amphipathic | Conjugation with fluorescein | Amidation | NA | Fluorophore (Fluorescein) | 25016968 |
2176 | CSSLDEPGRGGFSSESKV | 1A | 18 | L | Linear | Protein derived | Cationic | Conjugation with fluorescein | Amidation | NA | Fluorophore (Fluorescein) | 25016968 |
2192 | K-Hey-FQWQRNMRKVRGPPVS-Hey-IKR | hLF Hcy | 20 | Modified | Linear | Protein derived | Cationic | Conjugation with 5(6)-Carboxyfluorescein | Amidation | hcy, homocysteine in which the side chain is one methylene group longer than in cysteine | Fluorophore (Fluorescein) | 24270856 |
2197 | LLKLLKKLLKLLKKLLKLL | PF20 | 19 | L | Linear | Synthetic | Amphipathic | Stearylation | Amidation | NA | Nucleic acid (Plasmid DNA) | 24463071 |
2198 | WLKLLKKWLKLWKKLLKLW | PF21 | 19 | L | Linear | Synthetic | Amphipathic | Stearylation | Amidation | NA | Nucleic acid (Plasmid DNA) | 24463071 |
2199 | FLKLLKKFLKLFKKLLKLF | PF22 | 19 | L | Linear | Synthetic | Amphipathic | Stearylation | Amidation | NA | Nucleic acid (Plasmid DNA) | 24463071 |
2200 | WLOLLOOWLOLWOOLLOLW | PF23 | 19 | Modified | Linear | Synthetic | Amphipathic | Stearylation | Amidation | O, Ornithine | Nucleic acid (Plasmid DNA) | 24463071 |
2201 | WLOLLROWLRLWORLLOLW | PF24 | 19 | Modified | Linear | Synthetic | Amphipathic | Stearylation | Amidation | O, Ornithine | Nucleic acid (Plasmid DNA) | 24463071 |
2202 | WLRLLORWLOLWROLLRLW | PF25 | 19 | Modified | Linear | Synthetic | Amphipathic | Stearylation | Amidation | O, Ornithine | Nucleic acid (Plasmid DNA) | 24463071 |
2203 | WLKY(PO3)LLKKWLKLWKKLLKLW | PF26 | 20 | Modified | Linear | Synthetic | Amphipathic | Stearylation | Amidation | NA | Nucleic acid (Plasmid DNA) | 24463071 |
2204 | Y(PO3)WLKLLKKWLKLWKKLLKLW | PF27 | 20 | Modified | Linear | Synthetic | Amphipathic | Stearylation | Amidation | NA | Nucleic acid (Plasmid DNA) | 24463071 |
2206 | KALKLKLALALLAKLKLA | NAP | 18 | L | Linear | Synthetic | Non-Amphipathic | Free | Amidation | NA | Nucleic acid (Plasmid DNA) | 24463071 |
2207 | KALKLKLALALLAKLKLA | Stearyl-NAP | 18 | L | Linear | Synthetic | Non-Amphipathic | Stearylation | Amidation | NA | Nucleic acid (Plasmid DNA) | 24463071 |
2210 | RRWRRWWRRWWRRWRR | RW16 | 16 | L | Linear | Synthetic | Amphipathic | Free | Free | NA | Nanoparticle (PMS labelled with the fluorescent probe di-4-ANEPPDHQ) | 24583633 |
2214 | BXRXRXXRXRXXRXRX | FAM-3 | 16 | Modified | Linear | Synthetic | Amphipathic | FAM linked with beta-alanine | Amidation | B, Beta-Alanine; X, α-amino isobutyric acid | Fluorophore (FAM) | 24661993 |
2215 | IPLVVPLRRRRRRRRC | RIPL | 16 | L | Linear | Chimeric | Cationic | Free | Free | RIPL peptides is conjugated to maleimide-derivatized liposomal vesicles via the thiol-maleimide reaction | Fluorophore (FITC) | 24704199 |
2218 | KFLNRFWHWLQLKPGQPMY | IP-1 | 19 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore (Hilytefluor 488 and TAMARA) | 24706763 |
2219 | KFLNRFWHWLQLKPGQPMY | TAMRA-IP-1 | 19 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore (TAMRA) | 24706763 |